Analgesic potential of NEO6860, a modality selective TRPV1 antagonist, in osteoarthritis knee pain: Results of a randomized, controlled, proof-of-concept trial

Authors
Category Primary study
JournalArthritis and Rheumatology
Year 2017
This article has no abstract
Epistemonikos ID: d5f61b5ada506b2b4d9220356fc3246064f05b87
First added on: Feb 08, 2025